The Adverse Events Specialist Role: Providing On-Demand Adverse Event Support to Clinical Staff
Specialty drugs, used to treat complex conditions, may cost from $10,000 to $100,000 or even more per therapy course. Growth in the use of specialty drugs continues to outpace the overall drug market. As reported by the Drug Channels Institute 2020 Report, specialty drugs now account for 36% of total pharmacy revenue, a new high. Some of the top specialty therapy classes in terms of spending per member per year include rheumatoid arthritis, multiple sclerosis, and cancer.
Unfortunately, even though they are often prescribed to treat debilitating or even fatal diseases, adherence rates for self-administered specialty drugs are often as distressingly low as those of their non-specialty counterparts. For example, adherence rates for patients with breast cancer reportedly range from 15%-87%, with a mean of just 50%. For oral cancer meds, nonadherence may be affecting 30%-80% of patients. Of course, poor adherence to specialty medications such as oral oncolytics can lead to disease progression and even death. Hit the "download" button below to learn more.